QXO (QXO) had the highest return between November 1, 2023 and January 1, 2024 by a mid-cap US stock, returning 443.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
QXO (QXO) | 11/1/2023 - 1/1/2024 | 443.17% |
CleanSpark (CLSK) | 11/1/2023 - 1/1/2024 | 162.62% |
Cytokinetics (CYTK) | 11/1/2023 - 1/1/2024 | 139.02% |
Twist Bioscience (TWST) | 11/1/2023 - 1/1/2024 | 134.63% |
Kymera Therapeutics (KYMR) | 11/1/2023 - 1/1/2024 | 121.78% |
TransMedics (TMDX) | 11/1/2023 - 1/1/2024 | 112.23% |
Rhythm Pharmaceuticals (RYTM) | 11/1/2023 - 1/1/2024 | 99.61% |
Akero Therapeutics (AKRO) | 11/1/2023 - 1/1/2024 | 95.56% |
Viking Therapeutics (VKTX) | 11/1/2023 - 1/1/2024 | 91.07% |
Compass (COMP) | 11/1/2023 - 1/1/2024 | 88.94% |
Recursion Pharmaceuticals (RXRX) | 11/1/2023 - 1/1/2024 | 88.17% |
Compania de Minas Buenaventura SAA ADR (BVN) | 11/1/2023 - 1/1/2024 | 86.08% |
Newmark (NMRK) | 11/1/2023 - 1/1/2024 | 84.91% |
Ast Spacemobile (ASTS) | 11/1/2023 - 1/1/2024 | 82.73% |
ODDITY Tech Ltd Class A Ordinary Shares (ODD) | 11/1/2023 - 1/1/2024 | 82.11% |
StoneCo (STNE) | 11/1/2023 - 1/1/2024 | 81.94% |
Dream Finders Homes (DFH) | 11/1/2023 - 1/1/2024 | 81.65% |
DigitalOcean (DOCN) | 11/1/2023 - 1/1/2024 | 81.36% |
Oscar Health (OSCR) | 11/1/2023 - 1/1/2024 | 80.12% |
Companhia Siderurgica Nacional ADR (SID) | 11/1/2023 - 1/1/2024 | 77.54% |
PagSeguro Digital (PAGS) | 11/1/2023 - 1/1/2024 | 77.38% |
Silicon Laboratories (SLAB) | 11/1/2023 - 1/1/2024 | 76.13% |
Madrigal Pharmaceuticals (MDGL) | 11/1/2023 - 1/1/2024 | 75.06% |
Avidity Biosciences (RNA) | 11/1/2023 - 1/1/2024 | 75.05% |
Sprint Communications (S) | 11/1/2023 - 1/1/2024 | 75% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
